Common Contracts
13 similar Registration Rights Agreement contracts by ChromaDex Corp., CalciMedica, Inc. /DE/, Communications Systems Inc, others
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 5th, 2024 • Protara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of April 5, 2024 by and among Protara Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 22nd, 2023 • CalciMedica, Inc. /DE/ • Pharmaceutical preparations • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of November 21, 2022 by and among CalciMedica, Inc., a Delaware corporation, and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 3rd, 2022 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of September 30, 2022, by and among ChromaDex Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and each purchaser signatory hereto (each, a “Purchaser” and collectively to the extent there is more than one Purchaser, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 29th, 2021 • Communications Systems Inc • Telephone & telegraph apparatus • New York
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of June 28, 2021 by and among Communications Systems, Inc., a Minnesota corporation (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 22nd, 2021 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of February 20, 2021 by and between ChromaDex Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the purchaser signatory hereto (the “Purchaser”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 30th, 2020 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of December 22, 2020 by and among Yumanity Therapeutics, Inc. (formerly known as Proteostasis Therapeutics, Inc.), a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 15th, 2020 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of , 2020 by and among Proteostasis Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 29th, 2020 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of April 27, 2020 by and among ChromaDex Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 24th, 2019 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of September 23, 2019 by and among Proteon Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 15th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of August 15, 2019 by and among ChromaDex Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 10th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of May 9, 2019 by and among ChromaDex Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 6th, 2017 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of November 3, 2017 by and among ChromaDex Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 2nd, 2017 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of April 29, 2017 by and among ChromaDex Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”).
